Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
TLR9 agonist immunomodulator treatment of cutaneous T-cell lymphoma (CTCL) with CPG7909. 46th Annual Meeting of the American-Society-of-Hematology Kim, Y., Girardi, M., Duvic, M., Kuzel, T., Rook, A., Link, B., Pinter-Brown, L., Comerci, C., McAuley, S., Schmalbach, T. AMER SOC HEMATOLOGY. 2004: 212A–213A
View details for Web of Science ID 000225127500745